Kennedy Krieger Institute

ACSVL3- A Novel Therapeutic Target in Malignant Glioma

Principal Investigator: Paul Watkins, MD, PhD

Institute: Kennedy Krieger Inst.

Initiative: Standard Research Grant

Location: Baltimore, MD

Anti-HGF Monoclonal Antibody Therapy for Malignant Glioma

Principal Investigator: John Laterra, MD, PhD

Institute: Kennedy Krieger Inst.

Initiative: Unrestricted Grant

Location: Baltimore, MD

Principal Investigator: John Laterra, MD, PhD

Institute: Kennedy Krieger Inst.

Initiative: Unrestricted Grant

Location: Baltimore, MD

Share